Nonsurgical treatment of hepatocellular carcinoma

被引：75

作者：

Aguayo, A

Patt, YZ

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Dept Med Oncol, Div Med, Houston, TX 77030 USA

[2] Univ Texas, MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Div Med, Houston, TX 77030 USA

来源：

SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 05期

关键词：

D O I：

10.1053/sonc.2001.26953

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：503 / 513

页数：11

共 134 条

[1] Current status of pyrazoloacridine as an anticancer agent [J].

Adjei, AA .

INVESTIGATIONAL NEW DRUGS, 1999, 17 (01) :43-48

[2] The angiogenesis inhibitor TNP-470 (AGM-1470) improves long-term survival of rats with liver metastasis [J].

Ahmed, MH ;

Konno, H ;

Nahar, L ;

Tanaka, T ;

Naito, Y ;

Nakamura, S ;

Baba, S .

JOURNAL OF SURGICAL RESEARCH, 1996, 64 (01) :35-41

[3]

Akriviadis EA, 1998, BRIT J SURG, V85, P1319

[4] The effects of hepatic cryosurgery on tumor growth in the liver [J].

Allen, PJ ;

D'Angelica, M ;

Hodyl, C ;

Lee, J ;

You, YJ ;

Fong, YM .

JOURNAL OF SURGICAL RESEARCH, 1998, 77 (02) :132-136

[5] Expression of vascular endothelial growth factor in surgical specimens of hepatocellular carcinoma [J].

An, FQ ;

Matsuda, M ;

Fujii, H ;

Matsumoto, Y .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2000, 126 (03) :153-160

[6]

Arii S, 1996, SEMIN SURG ONCOL, V12, P204, DOI 10.1002/(SICI)1098-2388(199605/06)12:3<204::AID-SSU11>3.3.CO

[7]

2-A

[8]

ATIQ OT, 1992, CANCER, V69, P920, DOI 10.1002/1097-0142(19920215)69:4<920::AID-CNCR2820690414>3.0.CO

[9]

2-Y

[10]

Bartolozzi C, 1996, EUR RADIOL, V6, P682

← 1 2 3 4 5 6 7 8 9 10 →